dimethoxyphenylethylamine has been researched along with 4-iodo-2,5-dimethoxy-beta-phenethylamine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Maurer, HH; Pütz, M; Schneider, E; Theobald, DS | 1 |
Drees, JC; Stone, JA; Wu, AH | 1 |
Bosak, A; Levine, M; LoVecchio, F | 1 |
Hegarty, CB; Janis, GC; Kealey, SE; Stellpflug, SJ | 1 |
Geyer, MA; Halberstadt, AL | 1 |
Armenian, P; Gerona, RR | 1 |
Anastasio, NC; Cunningham, KA; Fink, LH; Fox, RG; Moeller, FG; Rice, KC | 1 |
Halberstadt, AL | 1 |
Gerona, RR; Hoehn, S; Thornton, SL | 1 |
Cocchi, V; Gasperini, S; Hrelia, P; Lenzi, M; Marti, M; Tirri, M | 1 |
1 review(s) available for dimethoxyphenylethylamine and 4-iodo-2,5-dimethoxy-beta-phenethylamine
Article | Year |
---|---|
Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
Topics: Animals; Dimethoxyphenylethylamine; Ethylamines; Fever; Hallucinogens; Humans; Iodobenzenes; Mice; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rhabdomyolysis; Seizures; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Vasoconstriction | 2017 |
9 other study(ies) available for dimethoxyphenylethylamine and 4-iodo-2,5-dimethoxy-beta-phenethylamine
Article | Year |
---|---|
New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques.
Topics: Animals; Capillary Action; Designer Drugs; Dimethoxyphenylethylamine; Electrophoresis; Gas Chromatography-Mass Spectrometry; Male; Mass Spectrometry; Rats; Rats, Wistar | 2006 |
Morbidity involving the hallucinogenic designer amines MDA and 2C-I.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Chromatography, Gas; Designer Drugs; Dimethoxyphenylethylamine; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Intracranial Hemorrhages; Moyamoya Disease; Quadriplegia; Stroke; Substance Abuse Detection; Substance-Related Disorders | 2009 |
Recurrent seizures and serotonin syndrome following "2C-I" ingestion.
Topics: Adult; Designer Drugs; Dimethoxyphenylethylamine; Emergency Service, Hospital; Humans; Insufflation; Male; Phenethylamines; Respiratory Insufficiency; Seizures; Serotonin Syndrome; Substance-Related Disorders; Treatment Outcome; Young Adult | 2013 |
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Topics: Adolescent; Benzylamines; Biomarkers; Biotransformation; Designer Drugs; Dimethoxyphenylethylamine; Epilepsy, Tonic-Clonic; Female; Hallucinogens; Humans; Minnesota; Neurotoxicity Syndromes; Phenethylamines; Substance Abuse Detection; Treatment Outcome | 2014 |
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.
Topics: Animals; Dimethoxyphenylethylamine; Dose-Response Relationship, Drug; Hallucinogens; Mice; Mice, Inbred C57BL; Motor Activity; Serotonin 5-HT2 Receptor Agonists | 2014 |
The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man.
Topics: Chromatography, Liquid; Designer Drugs; Dimethoxyphenylethylamine; Emergency Treatment; Female; Humans; Mass Spectrometry; Nevada; Substance-Related Disorders; Young Adult | 2014 |
Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System.
Topics: Animals; Choice Behavior; Dimethoxyphenylethylamine; Fluorobenzenes; Head Movements; Immunoprecipitation; Impulsive Behavior; Individuality; Ketanserin; Male; Piperidines; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Tritium | 2015 |
Seizures, Systemic Inflammatory Response, and Rhabdomyolysis Associated With Laboratory-Confirmed 2C-I and 25-I Exposure.
Topics: Adolescent; Anticonvulsants; Chromatography, Liquid; Designer Drugs; Diagnosis, Differential; Dimethoxyphenylethylamine; Humans; Male; Rhabdomyolysis; Seizures; Systemic Inflammatory Response Syndrome | 2018 |
Novel Psychoactive Phenethylamines: Impact on Genetic Material.
Topics: Anisoles; Apoptosis; Cell Line; Cell Survival; Dimethoxyphenylethylamine; Flow Cytometry; Genes; Hallucinogens; Humans; Micronuclei, Chromosome-Defective; Micronucleus Tests; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Psychotropic Drugs; Reactive Oxygen Species | 2020 |